Literature DB >> 2354026

Recent advances in cellular immunology: implications for immunity to cancer.

M T Lotze1, O J Finn.   

Abstract

Basic immunologists, animal experimenters and clinicians came together earlier this year to discuss insights into, and applications of, cellular immunity to cancer. Major questions critical to the further evaluation and exploitation of the cellular immune response to cancer were explored. It was clear from this conference that there has been a move beyond phenomenology to reductionistic approaches to understanding immune events, raising hopes that the specificity of the T-cell response might be applied to the problem of human cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354026     DOI: 10.1016/0167-5699(90)90079-o

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  5 in total

1.  Effects of radical cholecystectomy on nutritional and immune status in patients with gallbladder carcinoma.

Authors:  Xing-Yuan Jiao; Jing-Sen Shi; Jian-Sheng Wang; Yi-Jun Yang; Ping He
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.

Authors:  Y Zaloom; L P Walsh; P McCulloch; G Gallagher
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

3.  Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.

Authors:  P McCulloch; G Gallagher; L P Walsh; Y Zaloom; J Xie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 4.  The dawn of vaccines for cancer prevention.

Authors:  Olivera J Finn
Journal:  Nat Rev Immunol       Date:  2017-12-27       Impact factor: 53.106

5.  Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.

Authors:  M Sivanandham; S D Scoggin; N Tanaka; M K Wallack
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.